Reduced dose direct oral anticoagulants and time-in-therapeutic-range defined warfarin in new-onset atrial fibrillation: a report from the nationwide FinACAF study

Alex Luojus, Mika Lehto, Olli Halminen, Ossi Lehtonen, Mikko Niemi, Konsta Teppo, Jaana Kuoppala, Jari Haukka, Jukka Putaala, Miika Linna, Pirjo Mustonen, Aapo Aro, Juha Hartikainen, Gregory Yoke Hong Lip, Kari Eino Juhani Airaksinen

Open source

DOI: 10.1093/ehjopen/oeaf046
Published: 2025-04-23
Container: European Heart Journal Open
Publisher: Oxford University Press (OUP)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/ehjopen/oeaf046,
  title = {Reduced dose direct oral anticoagulants and time-in-therapeutic-range defined warfarin in new-onset atrial fibrillation: a report from the nationwide FinACAF study},
  author = {Alex Luojus and Mika Lehto and Olli Halminen and Ossi Lehtonen and Mikko Niemi and Konsta Teppo and Jaana Kuoppala and Jari Haukka and Jukka Putaala and Miika Linna and Pirjo Mustonen and Aapo Aro and Juha Hartikainen and Gregory Yoke Hong Lip and Kari Eino Juhani Airaksinen},
  year = {2025},
  journal = {European Heart Journal Open},
  doi = {10.1093/ehjopen/oeaf046},
  url = {https://doi.org/10.1093/ehjopen/oeaf046}
}

RIS

TY  - JOUR
TI  - Reduced dose direct oral anticoagulants and time-in-therapeutic-range defined warfarin in new-onset atrial fibrillation: a report from the nationwide FinACAF study
AU  - Alex Luojus
AU  - Mika Lehto
AU  - Olli Halminen
AU  - Ossi Lehtonen
AU  - Mikko Niemi
AU  - Konsta Teppo
AU  - Jaana Kuoppala
AU  - Jari Haukka
AU  - Jukka Putaala
AU  - Miika Linna
AU  - Pirjo Mustonen
AU  - Aapo Aro
AU  - Juha Hartikainen
AU  - Gregory Yoke Hong Lip
AU  - Kari Eino Juhani Airaksinen
PY  - 2025
JO  - European Heart Journal Open
DO  - 10.1093/ehjopen/oeaf046
UR  - https://doi.org/10.1093/ehjopen/oeaf046
ER  -

APA

Luojus, A., Lehto, M., Halminen, O., Lehtonen, O., Niemi, M., Teppo, K., Kuoppala, J., Haukka, J., Putaala, J., Linna, M., Mustonen, P., Aro, A., Hartikainen, J., Lip, G. Y. H., & Airaksinen, K. E. J. (2025). Reduced dose direct oral anticoagulants and time-in-therapeutic-range defined warfarin in new-onset atrial fibrillation: a report from the nationwide FinACAF study. European Heart Journal Open. https://doi.org/10.1093/ehjopen/oeaf046

Source records

crossref · retrieved 2026-11-05T22:42:44.082Z